Access the full text.
Sign up today, get DeepDyve free for 14 days.
A. Henney, P. Wakeley, J. Michael, Davies, K. Foster, R. Hembry, G. Murphy, S. Humphries (1991)
Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization.Proceedings of the National Academy of Sciences of the United States of America, 88 18
S. Humphries, P. Talmud, E. Hawe, M. Bolla, I. Day, G. Miller (2001)
Apolipoprotein E4 and coronary heart disease in middle-aged men who smoke: a prospective studyThe Lancet, 358
S. Ye, S. Humphries, A. Henney (1998)
Matrix metalloproteinases: implication in vascular matrix remodelling during atherogenesis.Clinical science, 94 2
F. Mach, U. Schönbeck, J. Bonnefoy, J. Pober, P. Libby (1997)
Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: induction of collagenase, stromelysin, and tissue factor.Circulation, 96 2
S. Ye, C. Whatling, H. Watkins, A. Henney (1999)
Human stromelysin gene promoter activity is modulated by transcription factor ZBP‐89FEBS Letters, 450
H. Fickl, V. Antwerpen, G. Richards, Denys Westhuyzen, N. Davies, R. Walt, C. Merwe, R. Anderson (1996)
Increased levels of autoantibodies to cardiolipin and oxidised low density lipoprotein are inversely associated with plasma vitamin C status in cigarette smokers.Atherosclerosis, 124 1
Steve Humphries, Le‐ahn Luong, Philippa Talmud, M. Frick, Y. Kesäniemi, Amos Pasternack, M. Taskinen, M. Syvänne (1998)
The 5A/6A polymorphism in the promoter of the stromelysin-1 (MMP-3) gene predicts progression of angiographically determined coronary artery disease in men in the LOCAT gemfibrozil study. Lopid Coronary Angiography Trial.Atherosclerosis, 139 1
D. Allen, N. Browse, D. Rutt, L. Butler, C. Fletcher (1988)
The effect of cigarette smoke, nicotine, and carbon monoxide on the permeability of the arterial wall.Journal of vascular surgery, 7 1
R. Doll, Hill Ab (1966)
Mortality of British doctors in relation to smoking: observations on coronary thrombosis.National Cancer Institute monograph, 19
A. Blann (1992)
The acute influence of smoking on the endothelium.Atherosclerosis, 96 2-3
P. Frosst, H. Blom, R. Milos, P. Goyette, C. Sheppard, R. Matthews, G. Boers, M. Heijer, L. Kluijtmans, L. Heuve, R. Rozen (1995)
A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 10
G. Miller, K. Bauer, S. Barzegar, A. Foley, J. Mitchell, J. Cooper, R. Rosenberg (1995)
The Effects of Quality and Timing of Venepuncture on Markers of Blood Coagulation in Healthy Middle-aged MenThrombosis and Haemostasis, 73
S. Feo, Vincenzo Antona, G. Cammarata, F. Cavaleri, R. Passantino, P. Rubino, A. Giallongo (2001)
Conserved structure and promoter sequence similarity in the mouse and human genes encoding the zinc finger factor BERF-1/BFCOL1/ZBP-89.Biochemical and biophysical research communications, 283 1
Jing Ma, M. Stampfer, C. Hennekens, P. Frosst, J. Selhub, J. Horsford, M. Malinow, W. Willett, R. Rozen (1996)
Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians.Circulation, 94 10
G. Miller, K. Bauer, S. Barzegar, J. Cooper, R. Rosenberg (1996)
Increased Activation of the Haemostatic System in Men at High Risk of Fatal Coronary Heart DiseaseThrombosis and Haemostasis, 75
J. Hokanson, M. Austin (1996)
Plasma Triglyceride Level is a Risk Factor for Cardiovascular Disease Independent of High-Density Lipoprotein Cholesterol Level: A Metaanalysis of Population-Based Prospective StudiesEuropean Journal of Cardiovascular Prevention & Rehabilitation, 3
U. Schönbeck, F. Mach, G. Sukhova, C. Murphy, J. Bonnefoy, R. Fabunmi, P. Libby (1997)
Regulation of matrix metalloproteinase expression in human vascular smooth muscle cells by T lymphocytes: a role for CD40 signaling in plaque rupture?Circulation research, 81 3
I. Inoue, Sei-ichi Goto, Kasumi Mizotani, T. Awata, Toshiyuki Mastunaga, Shin-ichiro Kawai, Takanori Nakajima, Shigeru Hokari, Tugikazu Komoda, Shigehiro Katayama (2000)
Lipophilic HMG-CoA reductase inhibitor has an anti-inflammatory effect: reduction of MRNA levels for interleukin-1beta, interleukin-6, cyclooxygenase-2, and p22phox by regulation of peroxisome proliferator-activated receptor alpha (PPARalpha) in primary endothelial cells.Life sciences, 67 8
R. Prineas, R. Crow, H. Blackburn (1982)
The Minnesota code manual of electrocardiographic findings : standards and procedures for measurement and classification
J. Powell (1998)
Vascular damage from smoking: disease mechanisms at the arterial wallVascular Medicine, 3
P. Talmud, S. Bujac, S. Hall, G. Miller, S. Humphries (2000)
Substitution of asparagine for aspartic acid at residue 9 (D9N) of lipoprotein lipase markedly augments risk of ischaemic heart disease in male smokers.Atherosclerosis, 149 1
J. Silence, F. Lupu, D. Collen, H. Lijnen (2001)
Persistence of Atherosclerotic Plaque but Reduced Aneurysm Formation in Mice With Stromelysin-1 (MMP-3) Gene InactivationArteriosclerosis, Thrombosis, and Vascular Biology: Journal of the American Heart Association, 21
W. Castelli, R. Garrison, P. Wilson, R. Abbott, S. Kalousdian, W. Kannel (1986)
Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study.JAMA, 256 20
J. Dalmon, M. Laurent, Gilles COURTOISt (1993)
The human beta fibrinogen promoter contains a hepatocyte nuclear factor 1-dependent interleukin-6-responsive elementMolecular and Cellular Biology, 13
Rongling Li, E. Boerwinkle, A. Olshan, L. Chambless, J. Pankow, H. Tyroler, M. Bray, G. Pittman, D. Bell, G. Heiss (2000)
Glutathione S-transferase genotype as a susceptibility factor in smoking-related coronary heart disease.Atherosclerosis, 149 2
(1982)
A basis for health policy on aging. Report from the World Health Organization Regional Office for Europe.Community medicine, 4 2
A. Newby, K. Southgate, M. Davies (1994)
Extracellular matrix degrading metalloproteinases in the pathogenesis of arteriosclerosis.Basic research in cardiology, 89 Suppl 1
Shu Ye, Gerald Watts, Sundhiya Mandalia, Steve Humphries, Adriano Henney (1994)
Preliminary report: genetic variation in the human stromelysin promoter is associated with progression of coronary atherosclerosis.British Heart Journal, 73
A. Bostom, L. Cupples, J. Jenner, J. Ordovás, L. Seman, P. Wilson, E. Schaefer, W. Castelli (1996)
Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study.JAMA, 276 7
(2001)
Lipoprotein ( a ) as a predictor for myocardial infarction in the Second Northwick Park Heart Study – a prospective study in middle - aged men
Shirley Miller, D. Dykes, H. Polesky (1988)
A simple salting out procedure for extracting DNA from human nucleated cells.Nucleic acids research, 16 3
E. Jensen, B. Pedersen, E. Narvestadt, R. Dahl (1998)
Blood eosinophil and monocyte counts are related to smoking and lung function.Respiratory medicine, 92 1
(1996)
High density lipoprotein cholesterol and mortality
M. Diaz-Meco, S. Quinones, M. Municio, Libia Sanz, Dolores Bernal, E. Cabrero, J. Saus, J. Moscat (1991)
Protein kinase C-independent expression of stromelysin by platelet-derived growth factor, ras oncogene, and phosphatidylcholine-hydrolyzing phospholipase C.The Journal of biological chemistry, 266 33
S. Ye, P. Eriksson, A. Hamsten, M. Kurkinen, S. Humphries, A. Henney (1996)
Progression of Coronary Atherosclerosis Is Associated with a Common Genetic Variant of the Human Stromelysin-1 Promoter Which Results in Reduced Gene Expression*The Journal of Biological Chemistry, 271
S. Bergmann, R. Siekmeier, C. Mix, W. Jaross (1998)
Even moderate cigarette smoking influences the pattern of circulating monocytes and the concentration of sICAM-1.Respiration physiology, 114 3
G. Lowe (1993)
Blood viscosity and cardiovascular riskCurrent Opinion in Lipidology, 4
M. Maat, M. Maat, J. Jukema, J. Jukema, Shu Ye, Shu Ye, A. Zwinderman, A. Zwinderman, Payman Moghaddam, Payman Moghaddam, M. Beekman, M. Beekman, J. Kastelein, A. Boven, A. Bruschke, A. Bruschke, S. Humphries, Cornelis Kluft, Cornelis Kluft, A. Henney, A. Henney (1999)
Effect of the stromelysin-1 promoter on efficacy of pravastatin in coronary atherosclerosis and restenosis.The American journal of cardiology, 83 6
(1999)
Stromelysin promoter 5 A } 6 A polymorphism is associated with acute myocardial infarction
C. Carty, P. Soloway, S. Kayastha, J. Bauer, B. Marsan, J. Ricotta, M. Dryjski (1996)
Nicotine and cotinine stimulate secretion of basic fibroblast growth factor and affect expression of matrix metalloproteinases in cultured human smooth muscle cells.Journal of vascular surgery, 24 6
Björn Eliasson, N. Mero, M. Taskinen, Ulf Smith (1997)
The insulin resistance syndrome and postprandial lipid intolerance in smokers.Atherosclerosis, 129 1
(1995)
Medical Research Council's Committee on Research into Chronic Bronchitis, Questionnaire on respiratory symptoms
M. Bolla, S. Martin, N. Wood, S. Humphries (2000)
Genotyping of the Stromelysin-1 5A/6A Promoter Polmorphism Using a Heteroduplex GeneratorThrombosis and Haemostasis, 83
R. Abbott, P. Wilson, W. Kannel, W. Castelli (1988)
High Density Lipoprotein Cholesterol, Total Cholesterol Screening, and Myocardial Infarction: The Framingham StudyArteriosclerosis, Thrombosis, and Vascular Biology, 8
K. Imai, Yasuo Yokohama, I. Nakanishi, E. Ohuchi, Yutaka Fujii, N. Nakai, Y. Okada (1995)
Matrix Metalloproteinase 7 (Matrilysin) from Human Rectal Carcinoma CellsThe Journal of Biological Chemistry, 270
T. Meade, M. Brozovīc, R. Chakrabarti, A. Haines, J. Imeson, S. Mellows, G. Miller, W. North, Y. Stirling, S. Thompson (1986)
HAEMOSTATIC FUNCTION AND ISCHAEMIC HEART DISEASE: PRINCIPAL RESULTS OF THE NORTHWICK PARK HEART STUDYThe Lancet, 328
U. Schönbeck, F. Mach, G. Sukhova, Elizabeth Atkinson, E. Levesque, M. Herman, P. Graber, P. Basset, P. Libby (1999)
Expression of Stromelysin-3 in Atherosclerotic Lesions: Regulation via CD40–CD40 Ligand Signaling In Vitro and In VivoThe Journal of Experimental Medicine, 189
S. Quinones, G. Buttice, Markku Kurkinen (1994)
Promoter elements in the transcriptional activation of the human stromelysin-1 gene by the inflammatory cytokine, interleukin 1.The Biochemical journal, 302 ( Pt 2)
G. Buttice, S. Quinones, M. Kurkinen (1991)
The AP-1 site is required for basal expression but is not necessary for TPA-response of the human stromelysin geneNucleic acids research, 19 13
Smoking is a major risk factor for coronary heart disease (CHD), but this risk may be modified by an individual's genotype. A common functional 5A/6A polymorphism in the promoter of the stromelysin‐1 (matrix metalloproteinase 3, MMP3) gene has been identified. The 6A allele has been consistently associated with faster progression of angiographically determined CHD, while the 5A allele has recently been associated with risk of acute myocardial infarction (MI) in patients with unstable angina. To date there has been no prospective study of the relationship of this genotype to CHD risk in smokers and non‐smokers.
Annals of Human Genetics – Wiley
Published: Jan 1, 2002
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.